Contact Us - Alpha Well

For inquiries or more information, please contact us.

Contact Details

Headquarters:
Level 4, Unit 350-407, Office A,
Labuan Times Square, Jalan Merdeka,
87000 Federal Territory of Labuan, Malaysia.

Marketing Office:
Level B-06-03 Tower B,
The Vertical Business Suite,
Avenue 3, Bangsar South,
No. 8 Jalan Kerinchi
Bangsar South,
59200 Kuala Lumpur.

support@alphawell.co

Select Investor Type:

Professional

Institutional

Professional

Institutional

QUICK LINKS
About Us
Services
Careers

Invest With Us

News & Articles

NEED HELP?
Get in touch with us at

support@alphawell.co

OPERATION HOURS

Monday – Friday

(10:00 am – 7:00 pm)

ADDRESS

ALPHA WELL LTD (LL14968)
License No. : FML/21/0051A

Headquarters:Level 4, Unit 350-407, Office A,
Labuan Times Square, Jalan Merdeka,
87000 Federal Territory of Labuan, Malaysia.

ADDRESS
Headquarters:Level 4, Unit 350-407, Office A,
Labuan Times Square, Jalan Merdeka,
87000 Federal Territory of Labuan, Malaysia.

Marketing Office:Level 3A-1, UOA Corporate Tower B, Avenue 10,
The Vertical, Bangsar South City,
No.8, Jalan Kerinchi, Bangsar South,
59200 Kuala Lumpur.

Disclaimer

The funds published in this website is offered by Alpha Well Ltd (“Alpha Well”) is intended for Professional Investors / Accredited & Institutional Investors/Qualified Investors ONLY as defined in your relevant jurisdiction.

These funds have been approved by, and the Prospectuses / Supplemental Prospectuses (if any) / Disclosure Document have been registered and the Information Memorandums / Supplemental Information Memorandums (if any) as well as the Product Highlights Sheet have been lodged with the Labuan Financial Services Authority Malaysia, who takes no responsibility for its contents. The Prospectuses / Supplemental Prospectuses (if any) / Information Memorandums / Supplemental Information Memorandums (if any) / Disclosure Document, and Product Highlights Sheet should not be deemed as an offer to sell or a solicitation of an offer to buy units in the funds to any person in any jurisdiction, in which such an offer, solicitation, purchase or sale would be unlawful under the securities laws or relevant laws of such jurisdiction. Any issue of units to which the Prospectuses / Supplemental Prospectuses (if any) / Information Memorandums / Supplemental Information Memorandums (if any) / Disclosure Document, and Product Highlights Sheet relates will only be made on receipt of an application referred to and accompanying a copy of the Prospectuses / Supplemental Prospectuses (if any) / Information Memorandums / Supplemental Information Memorandums (if any) / Disclosure Document, and Product Highlights Sheet.

Investors are advised to read and understand the contents of the Prospectuses / Supplemental Prospectuses (if any) / Information Memorandums / Supplemental Information Memorandums (if any) / Disclosure Document, and Product Highlights Sheet before investing. Among others, investors should consider the fees and charges involved. The price of units and distribution payable (if any) may go down as well as up, and past performance of the fund should not be taken as indicative of its future performance. If in doubt, please consult a professional adviser.

Do note that hardcopy of the Prospectuses / Supplemental Prospectuses (if any) / Information Memorandums / Supplemental Information Memorandums (if any) / Disclosure Document, and Product Highlights Sheet are also available at our offices. However, should you have any further enquiries, please do not hesitate to contact us, you may write to support@alphawell.co with your request or enquiries.

Risk Warning

Investment involves risks. Past performance is not necessarily a guide to future performance. The value of investments and the income from them may go down as well as up and that you may not get back your original investment. Please refer to the offering documents for details, including the risk factors. You should ensure you fully understand the risks associated with the investment and should also consider your own investment objective and risk tolerance level. If in doubt, please seek independent financial professional advice.

I confirm that I have read the important information.